Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials

Dipak Kotecha; Katherine Ngo; Julia A E Walters; Luis Manzano; Alberto Palazzuoli; Marcus D Flather

doi:10.1016/j.ahj.2011.02.013

Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials

Dipak Kotecha, Katherine Ngo, Julia A E Walters, Luis Manzano, Alberto Palazzuoli, Marcus D Flather

Research output: Contribution to journal › Article › peer-review

59 Citations (Scopus)

Abstract

Anemia in heart failure is both common and associated with worse symptoms and increased mortality. Several small randomized controlled trials (RCTs) have assessed erythropoiesis-stimulating agents (ESAs), but definitive evaluation and clinical guidance are required. We sought to systematically review the effects of ESAs in chronic heart failure.

Original language	English
Pages (from-to)	822-831.e2
Journal	American Heart Journal
Volume	161
Issue number	5
DOIs	https://doi.org/10.1016/j.ahj.2011.02.013
Publication status	Published - May 2011

Keywords

Anemia
Erythropoietin
Heart Failure
Humans
Randomized Controlled Trials as Topic
Treatment Outcome

Access to Document

10.1016/j.ahj.2011.02.013

Cite this

@article{b7b100d84b8547e580b178b56024d804,

title = "Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials",

abstract = "Anemia in heart failure is both common and associated with worse symptoms and increased mortality. Several small randomized controlled trials (RCTs) have assessed erythropoiesis-stimulating agents (ESAs), but definitive evaluation and clinical guidance are required. We sought to systematically review the effects of ESAs in chronic heart failure.",

keywords = "Anemia, Erythropoietin, Heart Failure, Humans, Randomized Controlled Trials as Topic, Treatment Outcome",

author = "Dipak Kotecha and Katherine Ngo and Walters, {Julia A E} and Luis Manzano and Alberto Palazzuoli and Flather, {Marcus D}",

year = "2011",

month = may,

doi = "10.1016/j.ahj.2011.02.013",

language = "English",

volume = "161",

pages = "822--831.e2",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Erythropoietin as a treatment of anemia in heart failure

T2 - systematic review of randomized trials

AU - Kotecha, Dipak

AU - Ngo, Katherine

AU - Walters, Julia A E

AU - Manzano, Luis

AU - Palazzuoli, Alberto

AU - Flather, Marcus D

PY - 2011/5

Y1 - 2011/5

N2 - Anemia in heart failure is both common and associated with worse symptoms and increased mortality. Several small randomized controlled trials (RCTs) have assessed erythropoiesis-stimulating agents (ESAs), but definitive evaluation and clinical guidance are required. We sought to systematically review the effects of ESAs in chronic heart failure.

AB - Anemia in heart failure is both common and associated with worse symptoms and increased mortality. Several small randomized controlled trials (RCTs) have assessed erythropoiesis-stimulating agents (ESAs), but definitive evaluation and clinical guidance are required. We sought to systematically review the effects of ESAs in chronic heart failure.

KW - Anemia

KW - Erythropoietin

KW - Heart Failure

KW - Humans

KW - Randomized Controlled Trials as Topic

KW - Treatment Outcome

U2 - 10.1016/j.ahj.2011.02.013

DO - 10.1016/j.ahj.2011.02.013

M3 - Article

C2 - 21570510

VL - 161

SP - 822-831.e2

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 5

ER -